Embedded Files
Our group has published in the Journal of Clinical Investigation, Journal of Allergy and Clinical Immunology, Journal of Allergy and Clinical Immunology: In Practice, Allergy, and Frontiers in Immunology. Please see below for a list of selected publications.
Our group has published in the Journal of Clinical Investigation, Journal of Allergy and Clinical Immunology, Journal of Allergy and Clinical Immunology: In Practice, Allergy, and Frontiers in Immunology. Please see below for a list of selected publications.
Selected Publications
Selected Publications
Schuler CF, Malinczak CA, Best SKK, Morris SH, Rasky AJ, Ptaschinski C, Lukacs NW, Fonseca W. Inhibition of uric acid or IL-1 ameliorates respiratory syncytial virus immunopathology and development of asthma. Allergy. 2020; 75(9):2279-2293.
Fonseca W, Malinczak CA, Schuler CF, Best SKK, Morris SH, Rasky AJ, Lukacs NW. Uric acid pathway activation during respiratory viral infection promotes Th2 immune responses via innate cytokine production and ILC2 accumulation. Mucosal Immunology. 2020; 13(4):691-701.
Schuler CF, Gherasim C, O’Shea K, Manthei, DM, Chen F, Zettel C, Troost JP, Giacherio DA, Valdez R, Baldwin JL, Baker JR Jr. Mild SARS-CoV-2 illness is not associated with reinfections and provides persistent spike, nucleocapsid, and virus neutralizing antibodies. Microbiology Spectrum. 2021. 9(2):e00087-21.
Schuler CF*, Volertas S*, Khokhar D, Yuce H, Chen L, Montejo J, Akin C. Prevalence of mastocytosis and hymenoptera venom allergy in the United States. Journal of Allergy and Clinical Immunology. 2021; S0091-6749(21)00652-7. *Contributed equally
Ganesan V, Sharma A, Tomar S, Schuler CF, Hogan SP. IL-4 receptor alpha signaling alters food challenge and oral immunotherapy outcomes in mice. Journal of Allergy and Clinical Immunology. 2022; S0091-6749(22)01021-1.
Sharma A, Rijavec M, Tomar S, Yamani A, Ganesan V, Krempski J, Schuler CF, Bunyavanich S, Korosec P, Hogan SP. Acute systemic myeloid inflammatory and stress response in severe food allergic reactions. Clinical and Experimental Allergy. 2022;00:1–14.
Hua A, El-Zaatari M, Hudson E, Sanders GM, Schuler CF. Evolution of FPIES trigger foods and subsequent reactions. Journal of Allergy and Clinical Immunology: In Practice. 2023;S2213-2198(23)00697-9.
O’Shea K*, Schuler CF*, Chen J, Troost JP, Wong P, Chen K, O’Shea D, Peng W, Gherasim C, Manthei DM, Valdez R, Baldwin JL, Baker JR Jr. Wild-type-induced SARS-CoV-2 neutralizing immunity decreases across variants and time and correlates with clinical testing. Frontiers in Immunology. 2023; 14:1055429 *Contributed equally.
Schuler CF, O’Shea KM, Troost JP, Kaul B, Launius CM, Cannon J, Manthei DM, Sanders G, Hogan SP, Lukacs NW*, Baker JR Jr*. Transepidermal water loss rises before food anaphylaxis and predicts food challenge outcomes. Journal of Clinical Investigation. 2023;133(16):e168965.
Schuler CF, Billi AC, Tsoi LC, Harms P, Weidinger S, Gudjonsson JE. Genetic and immunological pathogenesis of atopic dermatitis. Journal of Investigative Dermatology. 2023. Online ahead of print. Review.
Gallagher LA, Schuler CF, Troost JP, Slack IF, Sanders GM, Baker JR Jr, Smith JA, O'Shea KM. Racial and Socioeconomic Disparities Exist in Patients Pursuing Peanut Oral Immunotherapy. JACI: In Practice. 2024;12(8):2102-2108. doi: 10.1016/j.jaip.2024.04.040.
Gryak J*, Zhang J*, Najarian K, Ravikumar R, Sanders G, Schuler CF. Prediction of pediatric peanut oral food challenge outcomes using machine learning. JACI: Global. 2024;3(3):100252. *Contributed equally.
van Straalen KR, Kirma J, Yee CM, Bugada LF, Rizvi SM, Wen F, Wasikowski R, Fox J, Do TH, Schuler CF, Xing E, MacLeod AS, Harms PW, Berthier CC, Kahlenberg JM, Leung MWL, Tsoi LC, Gudjonsson JE. Disease heterogeneity and molecular classification of inflammatory palmoplantar diseases. JACI. 2024;S0091-6749(24)00746-2.
Idelman G, Rizza C, Marella S, Sharma A, Chakraborty S, Tay HL, Tomar S, Ganesan V, Schuler CF, Baker JR, Hogan SP. Inducible pluripotent stem cells to study human mast cell trajectories. Mucosal Immunol. 2024;S1933-0219(24)00069-2. doi: 10.1016/j.mucimm.2024.07.003.
Hua A, Slack I, O’Shea KM, Schuler CF. Adults with FPIES may face delayed diagnoses. Journal of Allergy and Clinical Immunology: Global. 2024 Jul 20;3(4):100304. doi: 10.1016/j.jacig.2024.100304.
Gard C, Slack I, Freigeh GE, Sanders G, Schuler CF, O’Shea KM. Oral immunotherapy referral patients tolerate entry oral food challenges at high rates. Journal of Allergy and Clinical Immunology: Global. 2025. Mar 19;4(20):100442
Sanders GM, Hua A, Hudson E, Troost JP, Kamada N, Kao JY, Schuler CF*, El-Zaatari M*. Association of Myeloid Cell Reactivity Patterns with Safe Food Predictions in FPIES Patients. Allergy, Asthma, and Clinical Immunology. 2025. 21:24. *Contributed equally.
Report abuse